NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 1.380

-9.2%

1:30 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: xcentral1	10/5/2009 9:10:13 AM
	of 12871

NanoViricides Secures $4.3M in Financing NanoViricides, Inc. announced today that it has completed a number of financing activities. The Company has successfully raised more than $4.3M. This raise involved issuance of restricted shares and warrant conversions in private placements to certain accredited investors. The Company is filing a Form 8-K disclosure with the SEC summarizing these activities on October 5, 2009. “With sufficient working capital to last us through December 31, 2010,” said Eugene Seymour, MD, MPH, CEO of the Company, “we are now ready to engage full steam with our high priority drug development activities.” NanoViricides, Inc.Amanda Schuon, 310-550-7200 info@nanoviricides.com : mailto:info@nanoviricides.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next